Stock listing
NASDAQ:MIRA MIRA Pharmaceuticals, Inc. Stock
Home listing (NASDAQ) of MIRA Pharmaceuticals, Inc.
Follow MIRA Pharmaceuticals, Inc. into a list and get an email when it puts out news.
Share price · NASDAQ:MIRA
$0.571 USD +0.030 (+5.6%)
Close on Nov 6, 2026
- Day range
- $0.540 – $0.588 USDNov 6, 2026
- Volume
- 28,127 sharesNov 6, 2026
- Market cap
- $23.97M USDAt the close on Nov 6, 2026 · price × 42.02M shares outstanding
- 52-week range
- $0.510 – $1.690 USDLowest and highest trades, Nov 7, 2025 – Nov 6, 2026
- Traded on an average day
- $477,862 USDMedian day 86,598 shares · last 3 months, Aug 6, 2026 – Nov 6, 2026
Prices by listing
| Listing | Last | Change | Volume | Open | High | Low | Previous close | Price from |
|---|---|---|---|---|---|---|---|---|
| NASDAQ:MIRA · Home | $0.571 USD | +0.030 (+5.6%) | 28,127 | $0.540 | $0.588 | $0.540 | $0.540 | Close on Nov 6, 2026 |
| Frankfurt:K6S | €0.486 EUR | +0.006 (+1.3%) | — | €0.484 | €0.486 | €0.484 | €0.480 | Close on Nov 5, 2026 |
Daily closes
Last 3 months, Aug 6, 2026 – Nov 6, 2026 · NASDAQ:MIRA · USD, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| $0.571 | +0.030 | +5.6% | $0.540 | $0.588 | $0.540 | 28,127 | |
| $0.540 | -0.021 | -3.7% | $0.568 | $0.575 | $0.520 | 115,014 | |
| $0.561 | +0.043 | +8.3% | $0.520 | $0.600 | $0.520 | 79,673 | |
| $0.518 | -0.019 | -3.6% | $0.530 | $0.550 | $0.511 | 83,091 | |
| $0.537 | -0.011 | -2.1% | $0.589 | $0.589 | $0.530 | 132,202 | |
| $0.549 | -0.023 | -4.0% | $0.589 | $0.589 | $0.510 | 207,648 | |
| $0.572 | +0.015 | +2.8% | $0.574 | $0.630 | $0.552 | 374,990 | |
| $0.556 | +0.006 | +1.1% | $0.550 | $0.578 | $0.546 | 54,239 | |
| $0.550 | +0.017 | +3.2% | $0.540 | $0.569 | $0.539 | 86,796 | |
| $0.533 | -0.087 | -14.1% | $0.647 | $0.647 | $0.518 | 240,504 | |
| $0.620 | -0.009 | -1.4% | $0.630 | $0.660 | $0.600 | 106,100 | |
| $0.629 | -0.053 | -7.8% | $0.730 | $0.730 | $0.622 | 100,200 | |
| $0.682 | +0.032 | +4.9% | $0.665 | $0.693 | $0.665 | 128,700 | |
| $0.650 | +0.008 | +1.2% | $0.645 | $0.661 | $0.645 | 10,500 | |
| $0.642 | +0.010 | +1.6% | $0.626 | $0.647 | $0.623 | 66,100 | |
| $0.632 | -0.026 | -4.0% | $0.680 | $0.680 | $0.631 | 123,200 | |
| $0.658 | -0.024 | -3.5% | $0.635 | $0.679 | $0.626 | 128,600 | |
| $0.682 | +0.016 | +2.4% | $0.667 | $0.686 | $0.660 | 75,900 | |
| $0.666 | -0.039 | -5.5% | $0.699 | $0.700 | $0.660 | 67,700 | |
| $0.705 | -0.041 | -5.5% | $0.759 | $0.759 | $0.685 | 90,000 | |
| $0.746 | +0.043 | +6.1% | $0.720 | $0.750 | $0.703 | 52,400 | |
| $0.703 | -0.007 | -1.0% | $0.710 | $0.710 | $0.681 | 142,500 | |
| $0.710 | -0.002 | -0.3% | $0.722 | $0.741 | $0.703 | 67,700 | |
| $0.712 | -0.024 | -3.3% | $0.759 | $0.760 | $0.700 | 105,700 | |
| $0.736 | +0.006 | +0.8% | $0.730 | $0.750 | $0.711 | 86,400 | |
| $0.730 | +0.007 | +1.0% | $0.730 | $0.758 | $0.711 | 158,000 | |
| $0.723 | -0.122 | -14.4% | $0.840 | $0.850 | $0.620 | 667,700 | |
| $0.845 | -0.027 | -3.1% | $0.859 | $0.869 | $0.820 | 72,100 | |
| $0.872 | -0.031 | -3.4% | $0.870 | $0.900 | $0.865 | 61,400 | |
| $0.903 | +0.003 | +0.3% | $0.898 | $0.911 | $0.875 | 65,800 | |
| $0.900 | +0.060 | +7.1% | $0.860 | $0.900 | $0.850 | 94,700 | |
| $0.840 | -0.018 | -2.1% | $0.858 | $0.860 | $0.831 | 54,100 | |
| $0.858 | -0.048 | -5.3% | $0.936 | $0.940 | $0.850 | 118,600 | |
| $0.906 | +0.027 | +3.1% | $0.865 | $0.919 | $0.847 | 127,800 | |
| $0.879 | +0.047 | +5.6% | $0.821 | $0.900 | $0.798 | 387,600 | |
| $0.832 | +0.073 | +9.6% | $0.789 | $0.832 | $0.770 | 682,600 | |
| $0.759 | +0.039 | +5.4% | $0.730 | $0.760 | $0.722 | 131,400 | |
| $0.720 | +0.006 | +0.8% | $0.720 | $0.737 | $0.710 | 76,500 | |
| $0.714 | -0.039 | -5.2% | $0.753 | $0.754 | $0.714 | 71,500 | |
| $0.753 | -0.021 | -2.7% | $0.766 | $0.780 | $0.728 | 171,500 | |
| $0.774 | -0.015 | -1.9% | $0.789 | $0.820 | $0.774 | 105,500 | |
| $0.789 | +0.008 | +1.0% | $0.790 | $0.830 | $0.759 | 138,400 | |
| $0.781 | +0.005 | +0.6% | $0.771 | $0.794 | $0.756 | 53,200 | |
| $0.776 | +0.012 | +1.6% | $0.760 | $0.810 | $0.751 | 177,200 | |
| $0.764 | +0.024 | +3.2% | $0.735 | $0.850 | $0.735 | 338,500 | |
| $0.740 | -0.110 | -12.9% | $0.830 | $0.840 | $0.731 | 490,500 | |
| $0.850 | -0.010 | -1.2% | $0.857 | $0.935 | $0.825 | 575,000 | |
| $0.860 | +0.090 | +11.7% | $0.740 | $1.100 | $0.721 | 29,281,100 | |
| $0.770 | +0.020 | +2.7% | $0.750 | $0.782 | $0.750 | 44,300 | |
| $0.750 | -0.020 | -2.6% | $0.750 | $0.779 | $0.750 | 31,800 | |
| $0.770 | +0.020 | +2.7% | $0.750 | $0.778 | $0.740 | 44,100 | |
| $0.750 | -0.025 | -3.2% | $0.770 | $0.774 | $0.750 | 27,300 | |
| $0.775 | -0.013 | -1.6% | $0.800 | $0.810 | $0.768 | 34,700 | |
| $0.788 | +0.024 | +3.1% | $0.779 | $0.825 | $0.770 | 65,100 | |
| $0.764 | +0.054 | +7.6% | $0.720 | $0.820 | $0.720 | 117,400 | |
| $0.710 | -0.060 | -7.8% | $0.770 | $0.796 | $0.710 | 41,700 | |
| $0.770 | +0.005 | +0.7% | $0.760 | $0.800 | $0.760 | 41,100 | |
| $0.765 | -0.025 | -3.2% | $0.765 | $0.795 | $0.760 | 40,300 | |
| $0.790 | +0.010 | +1.3% | $0.800 | $0.810 | $0.774 | 60,000 | |
| $0.780 | +0.030 | +4.0% | $0.782 | $0.811 | $0.766 | 75,500 | |
| $0.750 | +0.011 | +1.5% | $0.770 | $0.825 | $0.750 | 83,800 | |
| $0.739 | -0.039 | -5.0% | $0.773 | $0.785 | $0.738 | 26,400 | |
| $0.778 | +0.010 | +1.4% | $0.803 | $0.803 | $0.771 | 18,568 | |
| $0.767 | +0.027 | +3.7% | $0.759 | $0.790 | $0.741 | 114,143 | |
| $0.740 | +0.062 | +9.1% | $0.680 | $0.750 | $0.670 | 156,300 | |
| $0.678 | +0.020 | +3.0% | $0.698 | $0.698 | $0.659 | 71,400 |
- Ticker
- NASDAQ:MIRA
- Asset type
- Stock
- Sector
- Health care
- Industry
- Biotechnology
- Exchange
- NASDAQ
- Currency
- USD
What changed lately
Latest news release · Oct 29, 2026
MIRA Pharmaceuticals Reports Significant Weight and Fat Reduction With Oral SKNY-1 in Obese Mice, Showing Favorable Lean-Mass and Weight-Regain Outcomes Compared With Semaglutide
Latest deck · October 2026
Investor Presentation (October 2026)
Investor deck · 30 slides
Latest news
MIRA Pharmaceuticals Reports Significant Weight and Fat Reduction With Oral SKNY-1 in Obese Mice, Showing Favorable Lean-Mass and Weight-Regain Outcomes Compared With Semaglutide
Oct 29, 2026
Closed $0.572 (+2.8%) on Oct 29, 2026
MIRA Pharmaceuticals Reports MIRA-55 Demonstrated Significant Pain Relief Comparable to Celebrex in Chronic Inflammatory Pain Study
Oct 22, 2026
Closed $0.629 (-7.8%) on Oct 22, 2026
MIRA Pharmaceuticals Advances Ketamir-2 to Phase 2a in Chemotherapy-Induced Peripheral Neuropathy (CIPN) Following FDA Review
Sep 17, 2026
Closed $0.759 (+5.4%) on Sep 17, 2026
MIRA Pharmaceuticals Advances Non-Opioid Oral MIRA-55 for Inflammatory Pain Toward IND
Sep 1, 2026
Closed $0.86 (+11.7%) on Sep 1, 2026
MIRA Reports Positive 7-Day Dog Study Results for SKNY-1
Aug 6, 2026
Closed $0.678 (+3.0%) on Aug 6, 2026
MIRA Pharmaceuticals Progresses MIRA-55 and SKNY-1 Toward IND-Enabling Studies
Jul 30, 2026
Closed $0.816 (-3.1%) on Jul 30, 2026
MIRA Pharmaceuticals Reports Successful Formulation Results Supporting Development of MIRA-55 as a Non-Opioid Oral Therapy for Chronic Inflammatory Pain
Jul 10, 2026
Closed $0.925 (+0.5%) on Jul 10, 2026
MIRA Pharmaceuticals Reports Successful Formulation Results for SKNY-1, Its Oral Drug Candidate for Obesity and Addiction
Jul 6, 2026
Closed $0.955 (+1.1%) on Jul 6, 2026
MIRA Pharmaceuticals Reports New Preclinical Data Demonstrating Mira-55's Differentiated Mechanism of Action and Anxiolytic Activity Relative to THC
Jun 25, 2026
Closed $0.908 (-0.2%) on Jun 25, 2026
MIRA Pharmaceuticals Submits Phase 2a Clinical Trial Protocol to FDA for Ketamir-2 in Chemotherapy-Induced Peripheral Neuropathy
Jun 17, 2026
Closed $0.978 (+2.9%) on Jun 17, 2026
Decks
Investor Presentation (October 2026)
Investor deck · 30 slides · October 2026
Investor Presentation (April 2026)
Investor deck · 56 slides · April 2026
MIRA Pharmaceuticals, Inc. on 6ix
- Sector
- Health care
- Industry
- Biotechnology
- News releases
- 18 in the last 12 months · 78 in all · newest Oct 29, 2026 · oldest 2023
- Decks
- 2 decks · latest October 2026
Where MIRA Pharmaceuticals, Inc. is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| NASDAQ:MIRA · Home listing · This page | NASDAQ | United States | USD |
| gettex:K6S | gettex | Germany | EUR |
| Lang & Schwarz:A3EQWL | Lang & Schwarz | Germany | EUR |
| LS Exchange:A3EQWL | LS Exchange | Germany | EUR |
| BOATS:MIRA | BOATS | United States | USD |
| Tradegate:K6S | Tradegate | Germany | EUR |
| Dusseldorf:K6S | Dusseldorf | Germany | EUR |
| Frankfurt:K6S | Frankfurt | Germany | EUR |
| Hamburg:K6S | Hamburg | Germany | EUR |
| Munich:K6S | Munich | Germany | EUR |
| Stuttgart:K6S | Stuttgart | Germany | EUR |
Log in to ask 6ix AI your own questions about MIRA Pharmaceuticals, Inc.